跳至主要内容
临床试验/IRCT20120215009014N311
IRCT20120215009014N311尚未招募3 期

Effect mirtazapine versus placebo on the treatment of irritable bowel syndrome associated with diarrhea: a double-blind randomized clinical trial

Hamedan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Age of 18 to 65 years,
  • Irritable bowel syndrome associated with diarrhea

排除标准

  • Pregnancy or breastfeeding,
  • Taking antidepressants and anxiolytic drugs,
  • Taking anti-diarrhea drugs,
  • History of gastrointestinal surgery except for appendectomy,
  • Diabetes or cardiovascular diseases,
  • Liver or kidney failure,
  • Mental or psychiatric illnesses except for depression and anxiety

研究者

相似试验